Acetaminophen use during pregnancy shows no link to autism or ADHD in a large sibling-matched study, contradicting earlier warnings. Researchers analyzed 124,000 siblings and found no association regardless of dosage, trimester, or frequency of acetaminophen exposure. This method accounts for shared genetics and environment, strengthening the conclusion. Meanwhile, non-sibling studies suggesting a link were dismissed as flawed due to confounding factors.

The findings directly challenge claims from a Trump warning that linked the drug to autism, though the study notes older research using different designs showed conflicting results. When scientists compared acetaminophen-exposed children to unexposed ones without sibling matching, they found an association—later deemed biologically implausible. A 'negative control' analysis, comparing use before pregnancy or after birth, also showed nonsensical links. The researchers concluded these anomalies stem from family-related variables, not the drug itself. Similar sibling studies in Sweden and Japan reinforced these results.

This matters for consumer safety as acetaminophen remains a common painkiller during pregnancy. The study’s rigorous design undermines older claims, offering reassurance to parents. However, it doesn’t address post-birth use or other medications. While the science is clear here, public health guidelines may take time to update. The takeaway is that prenatal acetaminophen use appears safe for neurodevelopment, but broader questions about medication during pregnancy remain unanswered.